BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-7.42%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.38B
AUM Growth
+$5.38B
(-8.2%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
41.73%
Holding
223
New
22
Increased
133
Reduced
36
Closed
13
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$21.9M |
| 2 |
Glaukos
GKOS
|
$18.4M |
| 3 |
Arvinas
ARVN
|
$17.4M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$14.4M |
| 5 |
Becton Dickinson
BDX
|
$12.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$75.9M |
| 2 |
Gilead Sciences
GILD
|
$32.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 4 |
Teladoc Health
TDOC
|
$20M |
| 5 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$15.8M |
Sector Composition
| 1 | Healthcare | 94.28% |
| 2 | Industrials | 0.53% |
| 3 | Technology | 0.51% |
| 4 | Financials | 0.07% |
| 5 | Consumer Discretionary | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
76
DELISTED
NEVRO CORP.
NVRO
| $12.5M | 0.23% | 145,111 +4,563 | +3% | +$392K |
|
77
Omnicell
OMCL
$1.5B
| $12.4M | 0.23% | 171,646 +4,931 | +3% | +$356K |
|
78
Pacific Biosciences
PACB
$393M
| $12.2M | 0.23% | +2,373,787 | New | +$12.2M |
|
79
Tandem Diabetes Care
TNDM
$845M
| $11.5M | 0.21% | 194,736 +26,889 | +16% | +$1.59M |
|
80
Supernus Pharmaceuticals
SUPN
$2.53B
| $11.4M | 0.21% | 416,600 -50,400 | -11% | -$1.38M |
|
81
Amgen
AMGN
$155B
| $11.2M | 0.21% | 57,700 +11,100 | +24% | +$2.15M |
|
|
TRHC
82
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $11.1M | 0.21% | 201,693 +10,518 | +6% | +$578K |
|
|
OXFD
83
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $10.6M | 0.2% | 637,972 +59,357 | +10% | +$987K |
|
|
CHNG
84
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $10.4M | 0.19% | 863,922 -136,078 | -14% | -$1.64M |
|
85
Masimo
MASI
$7.59B
| $10.2M | 0.19% | 68,392 +2,800 | +4% | +$417K |
|
|
FIT
86
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $10.1M | 0.19% | 2,659,944 -1,036,586 | -28% | -$3.95M |
|
87
QuidelOrtho
QDEL
$1.95B
| $9.82M | 0.18% | 160,016 -108,454 | -40% | -$6.65M |
|
88
Cooper Companies
COO
$13.4B
| $9.5M | 0.18% | 31,969 | – | – |
|
89
Molina Healthcare
MOH
$9.8B
| $9.35M | 0.17% | 85,239 +3,578 | +4% | +$393K |
|
90
Idexx Laboratories
IDXX
$51.8B
| $9.28M | 0.17% | 34,134 +1,685 | +5% | +$458K |
|
|
ONC
91
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $8.98M | 0.17% | 72,100 -20,900 | -22% | -$2.6M |
|
92
Quanterix
QTRX
$211M
| $8.92M | 0.17% | 406,101 +8,532 | +2% | +$187K |
|
|
HZNP
93
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.8M | 0.16% | 323,300 +54,800 | +20% | +$1.49M |
|
94
Hologic
HOLX
$14.9B
| $7.84M | 0.15% | 155,208 +7,660 | +5% | +$387K |
|
|
XENT
95
DELISTED
Intersect ENT, Inc
XENT
| $7.8M | 0.15% | 458,588 +7,870 | +2% | +$134K |
|
96
Veeva Systems
VEEV
$44B
| $7.77M | 0.14% | 50,884 +1,294 | +3% | +$198K |
|
97
Biogen
BIIB
$19.4B
| $7.53M | 0.14% | 32,350 +2,800 | +9% | +$652K |
|
98
ResMed
RMD
$40.2B
| $7.38M | 0.14% | 54,630 +2,004 | +4% | +$271K |
|
99
Dentsply Sirona
XRAY
$2.85B
| $7.03M | 0.13% | 131,818 +6,505 | +5% | +$347K |
|
|
SGEN
100
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.94M | 0.13% | 81,300 +8,300 | +11% | +$709K |
|